Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-677-1 | CAS number: 14634-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No study available.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
For the examination of the effects of zinc ethylphenyldithiocarbamate (ZEPC) to the prenatal and postnatal development, gravid rats received 31.2, 62.5, 125 or 250 mg ZEPC/kg bw suspended in olive oil from day 7 to 15 of gravidity by oral gavage. Zinc ethyphenyldithiocarbamate has fetal toxic effects (fetal deaths, low body weights, skeletal variations and changes of the haematogram), however no external, visceral or skeletal anomalies were found in any of the dose groups examined. The toxic effects found may be due to methemoglobinemia.
In another study the test substance was applied into the air chamber of eggs onto the embryo. Volumes of 5 µl with doses of 2.5, 5.0, 7.5, 10.0 or 20.0 nM/egg were applied. Fourteen days after the incubation the surviving embryos were examined for malformations. A transfer of the results of chicken embryos to mammals is not possible due to resorption barriers and detoxification mechanisms (BG Chemie no. 219).
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Principles of method if other than guideline:
- For the examination of the effects of zinc ethylphenylthiocarbamate (ZEPC) to the prenatal and postnatal development, gravid rats received 31.2, 62.5, 125 or 250 mg ZEPC/kg bw suspended in olive oil from day 7 to 15 of gravidity by oral gavage.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- No data.
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on exposure:
- No data
- Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- No data
- Duration of treatment / exposure:
- From day 7 to 15 of gravidity.
- Frequency of treatment:
- Daily
- Duration of test:
- No data.
- Dose / conc.:
- 31.2 mg/kg bw/day (nominal)
- Dose / conc.:
- 62.5 mg/kg bw/day (nominal)
- Dose / conc.:
- 125 mg/kg bw/day (nominal)
- Dose / conc.:
- 250 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- No data
- Control animals:
- not specified
- Details on study design:
- No data.
- Maternal examinations:
- In a follow up experiment, a haemogram was conducted on rats which received daily doses of 125, 250, 500 or 1000 mg zinc ethylphenyldithiocarbamate/kg bw from day 7 to 9.
- Ovaries and uterine content:
- No data
- Fetal examinations:
- Haemogram
- Statistics:
- No data
- Indices:
- No data
- Historical control data:
- No data
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- A decrease in the number of erythrocytes, haemoglobin amount and haemotocrit value and an increase in microcyte count were observed in the gravid rats.
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Number of abortions:
- not specified
- Pre- and post-implantation loss:
- not specified
- Total litter losses by resorption:
- not specified
- Early or late resorptions:
- not specified
- Dead fetuses:
- effects observed, treatment-related
- Description (incidence and severity):
- With an increased dose of zink ethylphenylthiocarbamate an increased fetal mortality was observed. A dose of 250 mg zink ethylphenylthiocarbamate was lethal for all fetuses.
- Changes in pregnancy duration:
- not specified
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): not specified - Changes in number of pregnant:
- not specified
- Other effects:
- not specified
- Dose descriptor:
- NOAEL
- Remarks on result:
- other: not specified
- Abnormalities:
- effects observed, treatment-related
- Localisation:
- other: haematogram
- Description (incidence and severity):
- A decrease in the number of erythrocytes, haemoglobin amount and haemotocrit value and an increase in microcyte count were observed in the gravid rats.
- Fetal body weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- A decreased body weight of the fetuses of the dams of the 62.5 and 125 mg/kg bw group was observed.
Migrated Data from removed field(s)
Field "Fetal/pup body weight changes" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.FetalPupBodyWeightChanges): effects observed, treatment-related
Field "Description (incidence and severity)" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.DescriptionIncidenceAndSeverityFetalPupBodyWeightChanges): A decreased body weight of the fetuses of the dams of the 62.5 and 125 mg/kg bw group was observed. - Reduction in number of live offspring:
- not specified
- Changes in sex ratio:
- not specified
- Changes in litter size and weights:
- not specified
- Changes in postnatal survival:
- not specified
- External malformations:
- no effects observed
- Description (incidence and severity):
- No external, visceral or skeletal anomalies were found in any of the dose groups examined.
- Skeletal malformations:
- no effects observed
- Visceral malformations:
- no effects observed
- Description (incidence and severity):
- No external, visceral or sceletal anomalies were found in any of the dose groups examined.
- Other effects:
- effects observed, treatment-related
- Description (incidence and severity):
- Zinc ethyphenyldithiocarbamate has fetal toxic effecs, though the compound has no teratogenic effects and the fetal death od ZEPC may be due to an action of the agent on the erythrocytes of pregnant rats. It is concluded that methemoglobinemia in pregnant rats may be responsible for the in utero toxicity observed after exposure to ZEPC.
- Conclusions:
- Zinc ethyphenyldithiocarbamate has fetal toxic effects (fetal deaths, low body weights, skeletal variations, vhangeds of the haematogram), however no external, visceral or sceletal anomalies were found in any of the dose groups examined.
- Executive summary:
For the examination of the effects of zinc ethylphenylthiocarbamate (ZEPC) to the prenatal and postnatal development, gravid rats received 31.2, 62.5, 125 or 250 mg ZEPC/kg bw suspended in olive oil from day 7 to 15 of gravidity by oral gavage. Zinc ethyphenyldithiocarbamate has fetal toxic effects (fetal deaths, low body weights, skeletal variations and changes of the haematogram), however no external, visceral or skeletal anomalies were found in any of the dose groups examined. The toxic effects found may be due to methemoglobinemia.
Reference
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Toxicity to reproduction: other studies
Description of key information
No data.
Justification for classification or non-classification
For the examination of the effects of zinc ethylphenyldithiocarbamate (ZEPC) to the prenatal and postnatal development, gravid rats received 31.2, 62.5, 125 or 250 mg ZEPC/kg bw suspended in olive oil from day 7 to 15 of gravidity by oral gavage. Zinc ethyphenyldithiocarbamate has fetal toxic effects (fetal deaths, low body weights, skeletal variations and changes of the haematogram), however no external, visceral or skeletal anomalies were found in any of the dose groups examined. The toxic effects found may be due to methemoglobinemia.
According to CLP classification criteria (Regulation (EC) No 1272/2008) a classification is not justified.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.